nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Insomnia—Mycophenolic acid—systemic scleroderma	0.000868	0.000868	CcSEcCtD
Meropenem—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000864	0.000864	CcSEcCtD
Meropenem—Oedema—Lisinopril—systemic scleroderma	0.000864	0.000864	CcSEcCtD
Meropenem—Pruritus—Captopril—systemic scleroderma	0.000864	0.000864	CcSEcCtD
Meropenem—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000862	0.000862	CcSEcCtD
Meropenem—Pain—Leflunomide—systemic scleroderma	0.00086	0.00086	CcSEcCtD
Meropenem—Constipation—Leflunomide—systemic scleroderma	0.00086	0.00086	CcSEcCtD
Meropenem—Infection—Lisinopril—systemic scleroderma	0.000859	0.000859	CcSEcCtD
Meropenem—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000858	0.000858	CcSEcCtD
Meropenem—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Meropenem—Somnolence—Mycophenolic acid—systemic scleroderma	0.000853	0.000853	CcSEcCtD
Meropenem—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000853	0.000853	CcSEcCtD
Meropenem—Shock—Lisinopril—systemic scleroderma	0.00085	0.00085	CcSEcCtD
Meropenem—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000848	0.000848	CcSEcCtD
Meropenem—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000846	0.000846	CcSEcCtD
Meropenem—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000845	0.000845	CcSEcCtD
Meropenem—Neutropenia—Prednisone—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Meropenem—Tachycardia—Lisinopril—systemic scleroderma	0.000844	0.000844	CcSEcCtD
Meropenem—Abdominal pain—Azathioprine—systemic scleroderma	0.000842	0.000842	CcSEcCtD
Meropenem—Body temperature increased—Azathioprine—systemic scleroderma	0.000842	0.000842	CcSEcCtD
Meropenem—Skin disorder—Lisinopril—systemic scleroderma	0.00084	0.00084	CcSEcCtD
Meropenem—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000837	0.000837	CcSEcCtD
Meropenem—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000836	0.000836	CcSEcCtD
Meropenem—Diarrhoea—Captopril—systemic scleroderma	0.000835	0.000835	CcSEcCtD
Meropenem—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000834	0.000834	CcSEcCtD
Meropenem—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000832	0.000832	CcSEcCtD
Meropenem—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000831	0.000831	CcSEcCtD
Meropenem—Feeling abnormal—Leflunomide—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Meropenem—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000829	0.000829	CcSEcCtD
Meropenem—Nausea—Mometasone—systemic scleroderma	0.000825	0.000825	CcSEcCtD
Meropenem—Anorexia—Lisinopril—systemic scleroderma	0.000824	0.000824	CcSEcCtD
Meropenem—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000823	0.000823	CcSEcCtD
Meropenem—Pain—Mycophenolic acid—systemic scleroderma	0.000821	0.000821	CcSEcCtD
Meropenem—Constipation—Mycophenolic acid—systemic scleroderma	0.000821	0.000821	CcSEcCtD
Meropenem—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Meropenem—Cough—Mycophenolate mofetil—systemic scleroderma	0.00081	0.00081	CcSEcCtD
Meropenem—Hypotension—Lisinopril—systemic scleroderma	0.000808	0.000808	CcSEcCtD
Meropenem—Dizziness—Captopril—systemic scleroderma	0.000807	0.000807	CcSEcCtD
Meropenem—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000801	0.000801	CcSEcCtD
Meropenem—Urticaria—Leflunomide—systemic scleroderma	0.000799	0.000799	CcSEcCtD
Meropenem—Abdominal pain—Leflunomide—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Meropenem—Body temperature increased—Leflunomide—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Meropenem—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000794	0.000794	CcSEcCtD
Meropenem—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000791	0.000791	CcSEcCtD
Meropenem—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00079	0.00079	CcSEcCtD
Meropenem—Myocardial infarction—Prednisone—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Meropenem—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Meropenem—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000787	0.000787	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000786	0.000786	CcSEcCtD
Meropenem—Hypersensitivity—Azathioprine—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Meropenem—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Meropenem—Insomnia—Lisinopril—systemic scleroderma	0.000782	0.000782	CcSEcCtD
Meropenem—Paraesthesia—Lisinopril—systemic scleroderma	0.000776	0.000776	CcSEcCtD
Meropenem—Vomiting—Captopril—systemic scleroderma	0.000776	0.000776	CcSEcCtD
Meropenem—Dyspnoea—Lisinopril—systemic scleroderma	0.000771	0.000771	CcSEcCtD
Meropenem—Rash—Captopril—systemic scleroderma	0.00077	0.00077	CcSEcCtD
Meropenem—Dermatitis—Captopril—systemic scleroderma	0.000769	0.000769	CcSEcCtD
Meropenem—Somnolence—Lisinopril—systemic scleroderma	0.000768	0.000768	CcSEcCtD
Meropenem—Headache—Captopril—systemic scleroderma	0.000765	0.000765	CcSEcCtD
Meropenem—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000764	0.000764	CcSEcCtD
Meropenem—Dyspepsia—Lisinopril—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Meropenem—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000759	0.000759	CcSEcCtD
Meropenem—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000759	0.000759	CcSEcCtD
Meropenem—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Meropenem—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Meropenem—Asthma—Methotrexate—systemic scleroderma	0.000754	0.000754	CcSEcCtD
Meropenem—Infection—Mycophenolate mofetil—systemic scleroderma	0.000752	0.000752	CcSEcCtD
Meropenem—Decreased appetite—Lisinopril—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Meropenem—Eosinophilia—Methotrexate—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Meropenem—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000746	0.000746	CcSEcCtD
Meropenem—Shock—Mycophenolate mofetil—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Meropenem—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000743	0.000743	CcSEcCtD
Meropenem—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000742	0.000742	CcSEcCtD
Meropenem—Hypersensitivity—Leflunomide—systemic scleroderma	0.000741	0.000741	CcSEcCtD
Meropenem—Constipation—Lisinopril—systemic scleroderma	0.000739	0.000739	CcSEcCtD
Meropenem—Pain—Lisinopril—systemic scleroderma	0.000739	0.000739	CcSEcCtD
Meropenem—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000739	0.000739	CcSEcCtD
Meropenem—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000736	0.000736	CcSEcCtD
Meropenem—Bradycardia—Prednisone—systemic scleroderma	0.000736	0.000736	CcSEcCtD
Meropenem—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000732	0.000732	CcSEcCtD
Meropenem—Diarrhoea—Azathioprine—systemic scleroderma	0.000729	0.000729	CcSEcCtD
Meropenem—Haemoglobin—Prednisone—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Meropenem—Nausea—Captopril—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Meropenem—Haemorrhage—Prednisone—systemic scleroderma	0.000723	0.000723	CcSEcCtD
Meropenem—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Meropenem—Asthenia—Leflunomide—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Meropenem—Hallucination—Prednisone—systemic scleroderma	0.000719	0.000719	CcSEcCtD
Meropenem—Feeling abnormal—Lisinopril—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Meropenem—Pruritus—Leflunomide—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Meropenem—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Meropenem—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Meropenem—Neutropenia—Methotrexate—systemic scleroderma	0.000706	0.000706	CcSEcCtD
Meropenem—Dysuria—Methotrexate—systemic scleroderma	0.000706	0.000706	CcSEcCtD
Meropenem—Dizziness—Azathioprine—systemic scleroderma	0.000704	0.000704	CcSEcCtD
Meropenem—Asthenia—Mycophenolic acid—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Meropenem—Diarrhoea—Leflunomide—systemic scleroderma	0.000688	0.000688	CcSEcCtD
Meropenem—Urticaria—Lisinopril—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Meropenem—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000685	0.000685	CcSEcCtD
Meropenem—Abdominal pain—Lisinopril—systemic scleroderma	0.000683	0.000683	CcSEcCtD
Meropenem—Body temperature increased—Lisinopril—systemic scleroderma	0.000683	0.000683	CcSEcCtD
Meropenem—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00068	0.00068	CcSEcCtD
Meropenem—Pruritus—Mycophenolic acid—systemic scleroderma	0.000679	0.000679	CcSEcCtD
Meropenem—Vomiting—Azathioprine—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Meropenem—Pneumonia—Methotrexate—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Meropenem—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000675	0.000675	CcSEcCtD
Meropenem—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Meropenem—Infestation—Methotrexate—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Meropenem—Infestation NOS—Methotrexate—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Meropenem—Rash—Azathioprine—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Meropenem—Dermatitis—Azathioprine—systemic scleroderma	0.000671	0.000671	CcSEcCtD
Meropenem—Headache—Azathioprine—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Meropenem—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Meropenem—Dizziness—Leflunomide—systemic scleroderma	0.000665	0.000665	CcSEcCtD
Meropenem—Renal failure—Methotrexate—systemic scleroderma	0.000661	0.000661	CcSEcCtD
Meropenem—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000658	0.000658	CcSEcCtD
Meropenem—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000657	0.000657	CcSEcCtD
Meropenem—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000654	0.000654	CcSEcCtD
Meropenem—Immune system disorder—Prednisone—systemic scleroderma	0.000653	0.000653	CcSEcCtD
Meropenem—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Meropenem—Pain—Mycophenolate mofetil—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Meropenem—Sweating—Methotrexate—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Meropenem—Vomiting—Leflunomide—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Meropenem—Hypersensitivity—Lisinopril—systemic scleroderma	0.000637	0.000637	CcSEcCtD
Meropenem—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000636	0.000636	CcSEcCtD
Meropenem—Dizziness—Mycophenolic acid—systemic scleroderma	0.000635	0.000635	CcSEcCtD
Meropenem—Epistaxis—Methotrexate—systemic scleroderma	0.000635	0.000635	CcSEcCtD
Meropenem—Rash—Leflunomide—systemic scleroderma	0.000634	0.000634	CcSEcCtD
Meropenem—Dermatitis—Leflunomide—systemic scleroderma	0.000634	0.000634	CcSEcCtD
Meropenem—Nausea—Azathioprine—systemic scleroderma	0.000633	0.000633	CcSEcCtD
Meropenem—Headache—Leflunomide—systemic scleroderma	0.00063	0.00063	CcSEcCtD
Meropenem—Erythema—Prednisone—systemic scleroderma	0.000629	0.000629	CcSEcCtD
Meropenem—Agranulocytosis—Methotrexate—systemic scleroderma	0.000628	0.000628	CcSEcCtD
Meropenem—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000624	0.000624	CcSEcCtD
Meropenem—Asthenia—Lisinopril—systemic scleroderma	0.00062	0.00062	CcSEcCtD
Meropenem—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000619	0.000619	CcSEcCtD
Meropenem—Pruritus—Lisinopril—systemic scleroderma	0.000612	0.000612	CcSEcCtD
Meropenem—Vomiting—Mycophenolic acid—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Meropenem—Haemoglobin—Methotrexate—systemic scleroderma	0.000607	0.000607	CcSEcCtD
Meropenem—Rash—Mycophenolic acid—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Meropenem—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Meropenem—Hepatitis—Methotrexate—systemic scleroderma	0.000604	0.000604	CcSEcCtD
Meropenem—Haemorrhage—Methotrexate—systemic scleroderma	0.000604	0.000604	CcSEcCtD
Meropenem—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Meropenem—Headache—Mycophenolic acid—systemic scleroderma	0.000601	0.000601	CcSEcCtD
Meropenem—Pharyngitis—Methotrexate—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Meropenem—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Meropenem—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Meropenem—Nausea—Leflunomide—systemic scleroderma	0.000598	0.000598	CcSEcCtD
Meropenem—Diarrhoea—Lisinopril—systemic scleroderma	0.000591	0.000591	CcSEcCtD
Meropenem—Anaemia—Prednisone—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Meropenem—Agitation—Prednisone—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Meropenem—Angioedema—Prednisone—systemic scleroderma	0.000575	0.000575	CcSEcCtD
Meropenem—Dizziness—Lisinopril—systemic scleroderma	0.000572	0.000572	CcSEcCtD
Meropenem—Erythema multiforme—Methotrexate—systemic scleroderma	0.000571	0.000571	CcSEcCtD
Meropenem—Nausea—Mycophenolic acid—systemic scleroderma	0.00057	0.00057	CcSEcCtD
Meropenem—Malaise—Prednisone—systemic scleroderma	0.000567	0.000567	CcSEcCtD
Meropenem—Syncope—Prednisone—systemic scleroderma	0.000564	0.000564	CcSEcCtD
Meropenem—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Meropenem—Loss of consciousness—Prednisone—systemic scleroderma	0.000553	0.000553	CcSEcCtD
Meropenem—Vomiting—Lisinopril—systemic scleroderma	0.00055	0.00055	CcSEcCtD
Meropenem—Immune system disorder—Methotrexate—systemic scleroderma	0.000545	0.000545	CcSEcCtD
Meropenem—Rash—Lisinopril—systemic scleroderma	0.000545	0.000545	CcSEcCtD
Meropenem—Dermatitis—Lisinopril—systemic scleroderma	0.000545	0.000545	CcSEcCtD
Meropenem—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000543	0.000543	CcSEcCtD
Meropenem—Hypertension—Prednisone—systemic scleroderma	0.000543	0.000543	CcSEcCtD
Meropenem—Chills—Methotrexate—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Meropenem—Headache—Lisinopril—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Meropenem—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Meropenem—Anxiety—Prednisone—systemic scleroderma	0.000534	0.000534	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000532	0.000532	CcSEcCtD
Meropenem—Erythema—Methotrexate—systemic scleroderma	0.000526	0.000526	CcSEcCtD
Meropenem—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000518	0.000518	CcSEcCtD
Meropenem—Dysgeusia—Methotrexate—systemic scleroderma	0.000515	0.000515	CcSEcCtD
Meropenem—Nausea—Lisinopril—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Meropenem—Anaphylactic shock—Prednisone—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Meropenem—Oedema—Prednisone—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Meropenem—Infection—Prednisone—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Meropenem—Back pain—Methotrexate—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Meropenem—Shock—Prednisone—systemic scleroderma	0.000505	0.000505	CcSEcCtD
Meropenem—Nervous system disorder—Prednisone—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Meropenem—Tachycardia—Prednisone—systemic scleroderma	0.000501	0.000501	CcSEcCtD
Meropenem—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000501	0.000501	CcSEcCtD
Meropenem—Skin disorder—Prednisone—systemic scleroderma	0.000499	0.000499	CcSEcCtD
Meropenem—Hyperhidrosis—Prednisone—systemic scleroderma	0.000496	0.000496	CcSEcCtD
Meropenem—Anorexia—Prednisone—systemic scleroderma	0.000489	0.000489	CcSEcCtD
Meropenem—Anaemia—Methotrexate—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Meropenem—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000482	0.000482	CcSEcCtD
Meropenem—Rash—Mycophenolate mofetil—systemic scleroderma	0.000478	0.000478	CcSEcCtD
Meropenem—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Meropenem—Headache—Mycophenolate mofetil—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Meropenem—Malaise—Methotrexate—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Meropenem—Leukopenia—Methotrexate—systemic scleroderma	0.000471	0.000471	CcSEcCtD
Meropenem—Insomnia—Prednisone—systemic scleroderma	0.000464	0.000464	CcSEcCtD
Meropenem—Paraesthesia—Prednisone—systemic scleroderma	0.000461	0.000461	CcSEcCtD
Meropenem—Cough—Methotrexate—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Meropenem—Dyspepsia—Prednisone—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Meropenem—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00045	0.00045	CcSEcCtD
Meropenem—Chest pain—Methotrexate—systemic scleroderma	0.000448	0.000448	CcSEcCtD
Meropenem—Decreased appetite—Prednisone—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Meropenem—Constipation—Prednisone—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Meropenem—Confusional state—Methotrexate—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Meropenem—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Meropenem—Infection—Methotrexate—systemic scleroderma	0.000426	0.000426	CcSEcCtD
Meropenem—Feeling abnormal—Prednisone—systemic scleroderma	0.000423	0.000423	CcSEcCtD
Meropenem—Nervous system disorder—Methotrexate—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Meropenem—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Meropenem—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00042	0.00042	CcSEcCtD
Meropenem—Skin disorder—Methotrexate—systemic scleroderma	0.000417	0.000417	CcSEcCtD
Meropenem—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Meropenem—Anorexia—Methotrexate—systemic scleroderma	0.000409	0.000409	CcSEcCtD
Meropenem—Urticaria—Prednisone—systemic scleroderma	0.000408	0.000408	CcSEcCtD
Meropenem—Abdominal pain—Prednisone—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Meropenem—Body temperature increased—Prednisone—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Meropenem—Hypotension—Methotrexate—systemic scleroderma	0.000401	0.000401	CcSEcCtD
Meropenem—Insomnia—Methotrexate—systemic scleroderma	0.000388	0.000388	CcSEcCtD
Meropenem—Paraesthesia—Methotrexate—systemic scleroderma	0.000385	0.000385	CcSEcCtD
Meropenem—Dyspnoea—Methotrexate—systemic scleroderma	0.000383	0.000383	CcSEcCtD
Meropenem—Somnolence—Methotrexate—systemic scleroderma	0.000381	0.000381	CcSEcCtD
Meropenem—Hypersensitivity—Prednisone—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Meropenem—Dyspepsia—Methotrexate—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Meropenem—Decreased appetite—Methotrexate—systemic scleroderma	0.000373	0.000373	CcSEcCtD
Meropenem—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Meropenem—Asthenia—Prednisone—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Meropenem—Pain—Methotrexate—systemic scleroderma	0.000367	0.000367	CcSEcCtD
Meropenem—Pruritus—Prednisone—systemic scleroderma	0.000363	0.000363	CcSEcCtD
Meropenem—Feeling abnormal—Methotrexate—systemic scleroderma	0.000354	0.000354	CcSEcCtD
Meropenem—Diarrhoea—Prednisone—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Meropenem—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000351	0.000351	CcSEcCtD
Meropenem—Urticaria—Methotrexate—systemic scleroderma	0.000341	0.000341	CcSEcCtD
Meropenem—Dizziness—Prednisone—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Meropenem—Body temperature increased—Methotrexate—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Meropenem—Abdominal pain—Methotrexate—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Meropenem—Vomiting—Prednisone—systemic scleroderma	0.000326	0.000326	CcSEcCtD
Meropenem—Rash—Prednisone—systemic scleroderma	0.000324	0.000324	CcSEcCtD
Meropenem—Dermatitis—Prednisone—systemic scleroderma	0.000323	0.000323	CcSEcCtD
Meropenem—Headache—Prednisone—systemic scleroderma	0.000322	0.000322	CcSEcCtD
Meropenem—Hypersensitivity—Methotrexate—systemic scleroderma	0.000316	0.000316	CcSEcCtD
Meropenem—Asthenia—Methotrexate—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Meropenem—Nausea—Prednisone—systemic scleroderma	0.000305	0.000305	CcSEcCtD
Meropenem—Pruritus—Methotrexate—systemic scleroderma	0.000304	0.000304	CcSEcCtD
Meropenem—Diarrhoea—Methotrexate—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Meropenem—Dizziness—Methotrexate—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Meropenem—Vomiting—Methotrexate—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Meropenem—Rash—Methotrexate—systemic scleroderma	0.000271	0.000271	CcSEcCtD
Meropenem—Dermatitis—Methotrexate—systemic scleroderma	0.00027	0.00027	CcSEcCtD
Meropenem—Headache—Methotrexate—systemic scleroderma	0.000269	0.000269	CcSEcCtD
Meropenem—Nausea—Methotrexate—systemic scleroderma	0.000255	0.000255	CcSEcCtD
